Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 868.0M | 778.8M | 711.3M | 520.8M | -- |
| Operating Revenue | 868.0M | 778.8M | 711.3M | 520.8M | -- |
| Other Operating Expenses | 41.1M | 35.4M | 25.3M | 22.6M | -- |
| EBIT | 194.3M | 161.8M | 92.8M | 42.4M | -- |
| Interest Expense | 5.0M | 3.3M | 2.4M | 2.6M | -- |
| Interest Expense Non Operating | 5.0M | 3.3M | 2.4M | 2.6M | -- |
| Interest Income | 83.1M | 70.6M | 54.4M | 27.4M | -- |
| Net Interest Income | -5.0M | -3.3M | -2.4M | -2.6M | -- |
| Pretax Income | 189.3M | 158.5M | 90.4M | 39.7M | -- |
| Tax Provision | 47.0M | 39.6M | 23.5M | 11.9M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Income From Continuing Operation Net Minority Interest | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Income Including Noncontrolling Interests | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Income Common Stockholders | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Income | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Reconciled Depreciation | 3.9M | 1.4M | 1.7M | 3.6M | -- |
| Basic EPS | 2.98 | 2.50 | 1.44 | 0.64 | -- |
| Diluted EPS | 2.93 | 2.50 | 1.42 | 0.63 | -- |
| Basic Average Shares | 47.8M | 47.6M | 46.5M | 43.4M | -- |
| Diluted Average Shares | 48.6M | 47.6M | 47.3M | 44.3M | -- |
| Tax Rate For Calcs | 0.25 | 0.25 | 0.26 | 0.30 | -- |
| Normalized Income | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Diluted NI Availto Com Stockholders | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Loss Adjustment Expense | -216.8M | -213.1M | -123.5M | -123.1M | -- |
| Net Income Continuous Operations | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Non Operating Interest Income Expense | -5.0M | -3.3M | -2.4M | -2.6M | -- |
| Net Policyholder Benefits And Claims | -216.8M | -213.1M | -123.5M | -123.1M | -- |
| Policyholder Benefits Ceded | 2.1B | 2.2B | 1.7B | 1.3B | -- |
| Policyholder Benefits Gross | 1.9B | 2.0B | 1.6B | 1.2B | -- |
| Total Expenses | 678.7M | 620.3M | 620.9M | 481.0M | -- |
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 287.8M | 270.4M | 604.0M | 406.4M | -- |
| Cash Cash Equivalents And Short Term Investments | 1.7B | 1.4B | 1.2B | 1.2B | -- |
| Other Short Term Investments | 1.5B | 1.1B | 585.4M | 765.4M | -- |
| Accounts Receivable | -- | -- | -- | 433.2M | 285.4M |
| Receivables | 12.6M | 4.1M | 24.0M | 32.7M | -- |
| Prepaid Assets | 4.0M | 2.7M | 2.0M | 1.8M | -- |
| Net PPE | 27.9M | 13.4M | 12.3M | 15.1M | -- |
| Goodwill | 11.0M | 11.5M | 0.00 | -- | -- |
| Goodwill And Other Intangible Assets | 15.4M | 16.0M | 4.3M | 4.5M | -- |
| Other Intangible Assets | 4.4M | 4.5M | 4.3M | 4.5M | -- |
| Investments And Advances | 1.8B | 1.4B | 890.2M | 765.4M | -- |
| Total Assets | 5.0B | 4.6B | 3.6B | 2.8B | -- |
| Current Debt | 134.8M | 23.3M | 0.00 | 75.0M | -- |
| Current Debt And Capital Lease Obligation | 134.8M | 23.3M | 0.00 | 75.0M | -- |
| Accounts Payable | -- | -- | -- | 636.2M | 335.7M |
| Payables | 5.3M | 6.7M | 15.1M | 677.0M | -- |
| Payables And Accrued Expenses | 35.6M | 33.9M | 41.6M | 23.6M | -- |
| Current Accrued Expenses | 30.4M | 27.2M | 26.5M | 23.6M | -- |
| Long Term Debt | -- | 75.0M | 75.0M | 75.0M | 75.0M |
| Long Term Debt And Capital Lease Obligation | 22.3M | 84.3M | 84.7M | 86.7M | -- |
| Long Term Capital Lease Obligation | 22.3M | 9.3M | 9.7M | 11.7M | -- |
| Total Liabilities Net Minority Interest | 4.1B | 3.8B | 3.0B | 2.3B | -- |
| Common Stock | 472.1M | 481.8M | 481.0M | 430.3M | -- |
| Capital Stock | 472.1M | 481.8M | 481.0M | 430.3M | -- |
| Additional Paid In Capital | 14.0M | 9.8M | 7.5M | 5.7M | -- |
| Retained Earnings | 404.7M | 262.5M | 143.6M | 101.8M | -- |
| Gains Losses Not Affecting Retained Earnings | 33.8M | 31.2M | -12.7M | -44.2M | -- |
| Other Equity Adjustments | 33.8M | 31.2M | -12.7M | -44.2M | -- |
| Common Stock Equity | 924.7M | 785.3M | 619.4M | 493.7M | -- |
| Stockholders Equity | 924.7M | 785.3M | 619.4M | 493.7M | -- |
| Total Equity Gross Minority Interest | 924.7M | 785.3M | 619.4M | 493.7M | -- |
| Total Capitalization | 924.7M | 860.3M | 694.4M | 568.7M | -- |
| Net Tangible Assets | 909.3M | 769.3M | 615.1M | 489.2M | -- |
| Tangible Book Value | 909.3M | 769.3M | 615.1M | 489.2M | -- |
| Invested Capital | 1.1B | 883.5M | 694.4M | 568.7M | -- |
| Total Debt | 157.0M | 107.6M | 84.7M | 86.7M | -- |
| Share Issued | 47.8M | 47.8M | 47.6M | 45.8M | -- |
| Ordinary Shares Number | 47.4M | 47.6M | 47.4M | 45.8M | -- |
| Capital Lease Obligations | 22.3M | 9.3M | 9.7M | 11.7M | -- |
| Current Notes Payable | 75.0M | -- | -- | -- | -- |
| Derivative Product Liabilities | 549,000 | 1.6M | 0.00 | -- | 0.00 |
| Employee Benefits | 12.0M | 11.3M | 9.7M | 12.7M | -- |
| Income Tax Payable | 5.3M | 6.7M | 15.1M | 0.00 | -- |
| Line Of Credit | 59.8M | 23.3M | 0.00 | 75.0M | -- |
| Loans Receivable | -- | -- | -- | -- | 13.0M |
| Non Current Deferred Liabilities | -- | 694,000 | -- | 2.8M | -- |
| Non Current Deferred Taxes Liabilities | -- | 694,000 | -- | 2.8M | -- |
| Other Payable | -- | -- | -- | 23.8M | 8.3M |
| Other Receivables | -- | -- | 3.0M | 10.0M | 2.1M |
| Taxes Receivable | 12.6M | 4.1M | 24.0M | 22.8M | -- |
| Total Tax Payable | 5.3M | 6.7M | 15.1M | 0.00 | -- |
| Treasury Shares Number | 436,250 | 163,119 | 139,265 | -- | -- |
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 382.8M | 119.7M | 257.9M | 150.9M | -- |
| Cash Flow From Continuing Operating Activities | 382.8M | 119.7M | 257.9M | 150.9M | -- |
| Depreciation And Amortization | 3.9M | 1.4M | 1.7M | 3.6M | -- |
| Stock Based Compensation | 2.4M | 1.5M | 1.3M | 1.4M | -- |
| Change In Working Capital | 316.6M | 68.6M | 194.0M | 82.6M | -- |
| Changes In Account Receivables | -- | -- | -- | -155.3M | -116.7M |
| Change In Receivables | -- | -- | -- | -155.3M | -116.7M |
| Change In Payables And Accrued Expense | -- | -- | -- | 111.7M | 321.9M |
| Change In Payable | -- | -- | -- | 111.7M | 321.9M |
| Change In Other Working Capital | 46.1M | 23.3M | 18.8M | 10.7M | -- |
| Change In Other Current Assets | -2.3M | -17.4M | -647,000 | -30.3M | -- |
| Change In Other Current Liabilities | 8.2M | 55.1M | 46.8M | -65.4M | -- |
| Other Non Cash Items | -- | -- | -- | 81.5M | -- |
| Capital Expenditure | -5.1M | -3.8M | -714,000 | -2.1M | -- |
| Purchase Of PPE | -4.5M | -3.4M | -277,000 | -877,000 | -- |
| Net PPE Purchase And Sale | -4.5M | -3.4M | -277,000 | -877,000 | -- |
| Purchase Of Business | 0.00 | -15.0M | 0.00 | -- | -- |
| Purchase Of Investment | -733.2M | -795.3M | -219.1M | -384.0M | -- |
| Sale Of Investment | 350.6M | 342.3M | 102.5M | 144.2M | -- |
| Net Investment Purchase And Sale | -382.6M | -453.0M | -116.6M | -239.9M | -- |
| Investing Cash Flow | -387.7M | -471.8M | -117.3M | -242.0M | -- |
| Cash Flow From Continuing Investing Activities | -387.7M | -471.8M | -117.3M | -242.0M | -- |
| Issuance Of Debt | 36.5M | 46.6M | 0.00 | 30.0M | -- |
| Repayment Of Debt | -2.0M | -25.3M | -2.0M | -31.9M | -- |
| Net Issuance Payments Of Debt | 34.5M | 21.3M | -2.0M | -1.9M | -- |
| Issuance Of Capital Stock | 813,000 | 3.0M | 51.5M | 145.4M | -- |
| Repurchase Of Capital Stock | -7.8M | 0.00 | -- | -1.9M | -2.0M |
| Net Common Stock Issuance | -7.0M | 3.0M | 51.5M | 145.4M | -- |
| Common Stock Payments | -7.8M | 0.00 | -- | -1.9M | -2.0M |
| Financing Cash Flow | 24.8M | 22.0M | 48.1M | 141.6M | -- |
| Cash Flow From Continuing Financing Activities | 24.8M | 22.0M | 48.1M | 141.6M | -- |
| Effect Of Exchange Rate Changes | -2.5M | -3.6M | 9.0M | 14.5M | -- |
| Changes In Cash | 19.9M | -330.0M | 188.6M | 50.5M | -- |
| Beginning Cash Position | 270.4M | 604.0M | 406.4M | 341.3M | -- |
| End Cash Position | 287.8M | 270.4M | 604.0M | 406.4M | -- |
| Free Cash Flow | 377.7M | 115.9M | 257.2M | 148.8M | -- |
| Asset Impairment Charge | -- | -- | -895,000 | 3.0M | 529,000 |
| Change In Account Payable | -- | -- | -- | 111.7M | 321.9M |
| Change In Income Tax Payable | -- | -- | -- | 10.7M | 17.8M |
| Change In Tax Payable | -- | -- | -- | 10.7M | 17.8M |
| Common Stock Issuance | 813,000 | 3.0M | 51.5M | 145.4M | -- |
| Gain Loss On Investment Securities | -467,000 | -17,000 | 3.1M | -10.1M | -- |
| Interest Paid Cfo | -3.8M | -2.6M | -2.4M | -2.7M | -- |
| Long Term Debt Issuance | 36.5M | 46.6M | 0.00 | 30.0M | -- |
| Long Term Debt Payments | -2.0M | -25.3M | -2.0M | -31.9M | -- |
| Net Business Purchase And Sale | 0.00 | -15.0M | 0.00 | -- | -- |
| Net Income From Continuing Operations | 142.2M | 118.9M | 66.9M | 27.8M | -- |
| Net Intangibles Purchase And Sale | -658,000 | -437,000 | -437,000 | -1.3M | -- |
| Net Long Term Debt Issuance | 34.5M | 21.3M | -2.0M | -1.9M | -- |
| Operating Gains Losses | -467,000 | -17,000 | 3.1M | -10.1M | -- |
| Proceeds From Stock Option Exercised | -2.7M | -2.2M | -1.4M | -1.9M | -- |
| Purchase Of Intangibles | -658,000 | -437,000 | -437,000 | -1.3M | -- |
| Taxes Refund Paid | -59.1M | -42.3M | -9.8M | -31.1M | -- |
| Unrealized Gain Loss On Investment Securities | -19.0M | -25.8M | 3.2M | -5.2M | -- |